DONALD E KOHAN

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology SALT LAKE CITY, UT NPI 1235229840

General Payments — all program years on this page

$127,965.12

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 99
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $38,974.55 across 28 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $28,798.5218
Retrophin, Inc. $10,176.0310

By program year

Program yearAmountRecords
2018 $9,430.8010
2019 $625.001
2020 $22,248.2612
2021 $9,150.005
2022 $13,375.003
2023 $34,161.5140
2024 $38,974.5528

Records — PY2024 (28)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087121328 Novartis Pharmaceuticals Corporation $140.00 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087121330 Novartis Pharmaceuticals Corporation $7,200.00 02/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1087121332 Novartis Pharmaceuticals Corporation $209.97 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087121334 Novartis Pharmaceuticals Corporation $26.89 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087121336 Novartis Pharmaceuticals Corporation $431.52 02/09/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1087121338 Novartis Pharmaceuticals Corporation $368.88 02/09/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1087121340 Novartis Pharmaceuticals Corporation $88.26 02/09/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1087121350 Novartis Pharmaceuticals Corporation $2,600.00 06/06/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1087121352 Novartis Pharmaceuticals Corporation $3,900.00 06/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1087121360 Novartis Pharmaceuticals Corporation $3,725.00 07/31/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1087121364 Novartis Pharmaceuticals Corporation $139.13 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087121366 Novartis Pharmaceuticals Corporation $175.44 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087121368 Novartis Pharmaceuticals Corporation $20.96 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087121370 Novartis Pharmaceuticals Corporation $295.26 09/06/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1087121372 Novartis Pharmaceuticals Corporation $7,850.00 09/06/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1087121374 Novartis Pharmaceuticals Corporation $80.00 09/06/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1087121376 Novartis Pharmaceuticals Corporation $781.63 09/06/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1087121378 Novartis Pharmaceuticals Corporation $765.58 02/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1149936427 Travere Therapeutics, Inc. $2,583.00 10/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1149936431 Travere Therapeutics, Inc. $2,583.00 10/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1149936435 Travere Therapeutics, Inc. $118.39 10/14/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1149936439 Travere Therapeutics, Inc. $375.00 06/18/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1149936443 Travere Therapeutics, Inc. $375.00 06/18/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1149936447 Travere Therapeutics, Inc. $405.16 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149936451 Travere Therapeutics, Inc. $476.52 09/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1149936455 Travere Therapeutics, Inc. $676.96 09/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1149936459 Travere Therapeutics, Inc. $1,291.50 06/18/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1149936463 Travere Therapeutics, Inc. $1,291.50 06/18/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.